These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25678383)

  • 1. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.
    Park F; Russo K; Williams P; Pelosi M; Puddephatt R; Walter M; Leung C; Saaid R; Rawashdeh H; Ogle R; Hyett J
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):419-23. PubMed ID: 25678383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
    Ortved D; Hawkins TL; Johnson JA; Hyett J; Metcalfe A
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):239-244. PubMed ID: 29700870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
    Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
    O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
    BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.
    Yu CK; Papageorghiou AT; Parra M; Palma Dias R; Nicolaides KH;
    Ultrasound Obstet Gynecol; 2003 Sep; 22(3):233-9. PubMed ID: 12942493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPRE trial: performance of screening for preterm pre-eclampsia.
    Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal ophthalmic artery Doppler analysis for prediction of pre-eclampsia.
    Gurgel Alves JA; Praciano de Sousa PC; Bezerra Maia E Holanda Moura S; Kane SC; da Silva Costa F
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):411-8. PubMed ID: 24585555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.
    Plasencia W; Maiz N; Poon L; Yu C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):138-46. PubMed ID: 18634131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort.
    Oliveira N; Magder LS; Blitzer MG; Baschat AA
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):279-85. PubMed ID: 24913190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia.
    Verlohren S; Melchiorre K; Khalil A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):293-8. PubMed ID: 24448891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.
    Odibo AO; Goetzinger KR; Odibo L; Tuuli MG
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):414-8. PubMed ID: 25914193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study.
    Scazzocchio E; Oros D; Diaz D; Ramirez JC; Ricart M; Meler E; González de Agüero R; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):435-441. PubMed ID: 27807890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.
    Harrington K; Kurdi W; Aquilina J; England P; Campbell S
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):13-8. PubMed ID: 10776007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol.
    Mone F; Mulcahy C; McParland P; Stanton A; Culliton M; Downey P; McCormack D; Tully E; Dicker P; Breathnach F; Malone FD; McAuliffe FM
    Contemp Clin Trials; 2016 Jul; 49():143-8. PubMed ID: 27394381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
    Guy GP; Leslie K; Diaz Gomez D; Forenc K; Buck E; Khalil A; Thilaganathan B
    BJOG; 2021 Jan; 128(2):149-156. PubMed ID: 32613730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis.
    Baschat AA; Dewberry D; Seravalli V; Miller JL; Block-Abraham D; Blitzer MG
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):728-733. PubMed ID: 29266502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies.
    Zvanca ME; Bot M; Radu D; Radu N; Petca A
    J Matern Fetal Neonatal Med; 2019 Feb; 32(4):604-609. PubMed ID: 28974130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study.
    Lakovschek IC; Csapo B; Kolovetsiou-Kreiner V; Mayer-Pickel K; Reif P; Stern C; Ulrich D; Lang U; Obermayer-Pietsch B; Cervar-Zivkovic M
    J Matern Fetal Neonatal Med; 2018 Mar; 31(5):549-552. PubMed ID: 28162023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.